YGE [YINGLI GREEN ENERGY] 6-K: (Original Filing)

[Yingli Green Energy Reports Fourth Quarter and Full Year 2009 Results Fourth Quarter PV Module Shipmentsreased by 15.7% Quarter over Quarter BAODING, China, March8, 2010 Fourth Quarter 2009nsolidated Financial and Operating Highlights Total net revenues were RMB 2,530.9million (US$370.8million) and PV module shipment volumereased by 15.7% quarter over quarter, reaching a historical high.] [Yingli Green Energy Announces 300 MW PANDA Mono-Crystalline BAODING, China, March8, 2010 300 MW PANDA Mono-Crystalline Manufacturingpacity Expansion at Baoding Headquarters Yingli Green Energy announced its plan to build PANDA mono-crystalline silicon-based manufacturing lines with annual productionpacity of 300 MW in each of mono-crystalline ingots and wafers, cells and modules at its Baoding headquarters, through]

By | 2016-02-04T01:31:32+00:00 March 8th, 2010|Categories: Chinese Stocks, SEC Original, YGE|Tags: , , , , , |0 Comments

YGE [YINGLI GREEN ENERGY] 6-K: Yingli Green Energy Reports Fourth Quarter and Full

[Yingli Green Energy Reports Fourth Quarter and Full Year 2009 Results Fourth Quarter PV Module Shipmentsreased by 15.7% Quarter over Quarter BAODING, China, March8, 2010 Fourth Quarter 2009nsolidated Financial and Operating Highlights Total net revenues were RMB 2,530.9million (US$370.8million) and PV module shipment volumereased by 15.7% quarter over quarter, reaching a historical high.] [Yingli Green Energy Announces 300 MW PANDA Mono-Crystalline BAODING, China, March8, 2010 300 MW PANDA Mono-Crystalline Manufacturingpacity Expansion at Baoding Headquarters Yingli Green Energy announced its plan to build PANDA mono-crystalline silicon-based manufacturing lines with annual productionpacity of 300 MW in each of mono-crystalline ingots and wafers, cells and modules at its Baoding headquarters, through]

By | 2016-02-04T01:32:01+00:00 March 8th, 2010|Categories: Chinese Stocks, Webplus ver, YGE|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] SC 13G/A: (Original Filing)

[SCHEDULE 13G 3 (Amendment No.ystar Bio-Pharmaceuticalmpany (Name of Issuer)mmon Stock 830884102 May05,2009 o x o * The remainder of thisver page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendmentntaining information which wouldter the disclosures provided in a]

By | 2016-02-05T04:31:49+00:00 March 8th, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL] SC 13G/A: SCHEDULE 13G 3 (Amendment No.ystar Bio-Pharmaceuticalmpany (Name of

[SCHEDULE 13G 3 (Amendment No.ystar Bio-Pharmaceuticalmpany (Name of Issuer)mmon Stock 830884102 May05,2009 o x o * The remainder of thisver page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendmentntaining information which wouldter the disclosures provided in a]

By | 2016-02-05T04:32:39+00:00 March 8th, 2010|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments

DSWL [DESWELL INDUSTRIES] CORRESP: (Original Filing)

[Deswell Industries, 17B, Edificiomercial Rodrigues 599 Avenida Praia Grande Macao,ecialministrative Region, Tel: (853)322096 Fax: (853)323265 March8, 2010 Via EDGAR Terence OBrien Re: Deswell Industries, (Deswell or thempany) Dear Mr.OBrien: Form20-F for the Fiscal Year Ended March31, 2009 Note 2 Summary of Significant Accounting Policies, page F-6]

By | 2016-02-06T09:34:51+00:00 March 8th, 2010|Categories: Chinese Stocks, DSWL, SEC Original|Tags: , , , , , |0 Comments
Skip to toolbar